A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT
Swedish Orphan Biovitrum
Swedish Orphan Biovitrum
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)